Search | Search by Center | Search by Source | Keywords in Title
Good CB. VA response to FDA abuse-deterrent opioid medications initiative [invited presentation]. Presented at: Development and Regulation of Abuse-Deterrent Opioid Medications FDA Public Meeting; 2014 Oct 30; Silver Spring, MD.